LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microscope Lenses Include Higher Numerical Aperture Objectives

By Labmedica staff writers
Posted on 04 Jun 2008
A manufacturer of high precision ultraviolet (UV) optical systems has expanded its range of UV lenses to include a high numerical aperture (NA) UV microscope objective with a numerical aperture of 0.90. This complements the current high NA UV line that includes 0.75 NA and 0.50 NA objectives.

The features of high NA UV objectives are the diffraction limited design, the air spacing for high power applications, and the achromatic design. Therefore, the new line of UV lenses offers a higher level of performance compared with standard microscope objectives. The NA UV micro objective provides 0.28-micron spot imaging at a wavelength of 248 nm and 0.41-micron spot imaging at a wavelength of 365 nm. The effective focal length is 5.5 mm and the field of view is 100 microns.

The lenses were designed by Special Optics, Inc. (Wharton, New Jersey, USA), a company that supplies precision optical assemblies for high-technology applications, and serves the medical, defense, security, semiconductor, and commercial original equipment manufacturer (OEM) markets.

Special Optics is a Navitar (Rochester, NY, USA) company. Navitar supplies optics, optomechanical sub-assemblies, and optoelectronic solutions for microscopy, automation, nanotechnology, and other systems. It has offices and subsidiaries in the United States, Japan, Germany, China, Israel, and the United Kingdom.


Related Links:
Navitar
Special Optics
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more